Rethinking Routine Intensive Care After Cytoreductive Surgery With Heated Intraperitoneal Chemotherapy: The Fiscal Argument.
Patrick B SchwartzChristopher C StahlRoberto J VidriGlen E LeversonYana PuckettSyed N ZafarPatrick VarleySean M Ronnekleiv-KellyAhmed Al-NiaimiSharon M WeberDaniel E AbbottPublished in: Annals of surgical oncology (2022)
Selective admission to the IMC after CRS/HIPEC was associated with $2208.68 in savings per patient without added risk. In this era of cost-conscious practice of medicine, these data highlight an opportunity to decrease cost by more than 5% for patients undergoing CRS/HIPEC.
Keyphrases
- patients undergoing
- minimally invasive
- coronary artery bypass
- primary care
- emergency department
- healthcare
- case report
- electronic health record
- locally advanced
- big data
- surgical site infection
- quality improvement
- machine learning
- metastatic renal cell carcinoma
- atrial fibrillation
- coronary artery disease
- artificial intelligence
- data analysis